(E)-1-(4-(3-fluorobenzyl)piperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one

ID: ALA4873165

PubChem CID: 164624825

Max Phase: Preclinical

Molecular Formula: C21H23FN2O3

Molecular Weight: 370.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C/C(=O)N2CCN(Cc3cccc(F)c3)CC2)ccc1O

Standard InChI:  InChI=1S/C21H23FN2O3/c1-27-20-14-16(5-7-19(20)25)6-8-21(26)24-11-9-23(10-12-24)15-17-3-2-4-18(22)13-17/h2-8,13-14,25H,9-12,15H2,1H3/b8-6+

Standard InChI Key:  WCESATJMEGZLEK-SOFGYWHQSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   30.4204  -14.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4192  -15.2194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1273  -15.6284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8369  -15.2189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8341  -14.3963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1255  -13.9910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7126  -13.9914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.7124  -13.1742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7112  -15.6274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.5403  -13.9850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2495  -14.3909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9557  -13.9797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6649  -14.3856    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.6657  -15.2013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3709  -15.6072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0794  -15.1994    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0783  -14.3812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3686  -13.9709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9526  -13.1625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.7871  -15.6080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4949  -15.1994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2001  -15.6086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9073  -15.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9077  -14.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1951  -13.9742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4907  -14.3844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6148  -15.6096    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  2  9  1  0
  5 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 12 19  2  0
 16 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 23 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4873165

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.42Molecular Weight (Monoisotopic): 370.1693AlogP: 2.90#Rotatable Bonds: 5
Polar Surface Area: 53.01Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.89CX Basic pKa: 6.30CX LogP: 3.03CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.82Np Likeness Score: -0.87

References

1. Singh YP, Shankar G, Jahan S, Singh G, Kumar N, Barik A, Upadhyay P, Singh L, Kamble K, Singh GK, Tiwari S, Garg P, Gupta S, Modi G..  (2021)  Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.,  46  [PMID:34481338] [10.1016/j.bmc.2021.116385]

Source